Skip to main content

Table 5 COSMIC mutation analysis by considering genes related to PPIs predicted from best methods in our and PERA approaches and the relative amount of somatic and germline mutated genes

From: INBIA: a boosting methodology for proteomic network inference

Cancer type

Somatic mutation

Germline mutation

BLCA

ERBB3,NOTCH1,TSC1

–

BRCA

AKT1,ARID1A,BAP1,BRCA2,CCND1,CDH1,CDKN1B,

 
 

ERBB2,ESR1,NOTCH1,PIK3CA,RB1,TP53

BRCA2,CHEK2,RB1,TP53

 

AKT1,BRCA2,CCND1,CDH1,CDKN1B,ERBB2,ESR1,

BRCA2,CHEK2,TP53

 

GATA3,NOTCH1,PIK3CA,TP53

 

COAD

ERBB3

–

GBM

PIK3CA,PIK3R1

–

HNSC

ERBB3,MTOR,NOTCH1,TSC2

–

KIRC

MET,MTOR,NF2,TSC1,TSC2,VHL

MET,TSC1,TSC2,VHL

 

MET,MTOR,TSC1,TSC2,VHL

 

LGG

BRAF,EGFR,PTEN,RAF1,TP53

ATM,PTEN,TP53

LUAD

NOTCH1,RB1,TP53

RB1

 

–

–

LUSC

NOTCH1,RB1,TP53

RB1

 

TP53

–

OV

AKT1,ARID1A,BRAF,BRCA2,CCNE1,CTNNB1,ERBB2,

BRCA2,MSH2,MSH6,STK11

 

MAPK1,MSH2,PIK3R1

 
 

AKT1,BRAF,CCNE1,CTNNB1,ERBB2,MAPK1,PIK3R1

–

PRAD

AR,BRAF,NDRG1,PTEN,RAF1

PTEN

 

AR,BRAF,RAF1

–

READ

AKT1,BRAF,CTNNB1,MAP2K1,MSH2,MSH6,PIK3CA,

MSH2,MSH6

 

PIK3R1,SMAD3,SMAD4,SRC,TP53

 
 

AKT1,BRAF,CTNNB1,MAP2K1,PIK3CA,PIK3R1,SMAD3,SMAD4,SRC,TP53

–

SKCM

ERBB3,NOTCH1

–

STAD

BRAF,CDH1,ERBB2,ERBB3,PIK3CA

CDH1

THCA

BRAF,MTOR

CDKN1B

 

BRAF,NRAS

 

UCEC

MSH2,MTOR,PTEN,SRC

MSH2,MSH6,PTEN

 

MTOR,PTEN,SRC,YWHAE

PTEN

  1. For each cancer type, tuple highlighted in italic refers to our method (INBIA), the second one to PERA. When only one record per cancer type is present then it means that the two approaches achieved the same results